Document is current
Any future updates will be listed below
-
Authors
Kameda, Hideto http://orcid.org/0000-0002-4330-5782
Takeuchi, Tsutomu
Yamaoka, Kunihiro
Oribe, Motohiro
Kawano, Mitsuhiro
Yokoyama, Masayuki
Pangan, Aileen L.
Konishi, Yuko
Meerwein, Sebastian
Tanaka, Yoshiya
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 21 July 2020
Accepted: 7 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The study was conducted according to the International Conference on Harmonization of Technical Requirements for Pharmaceuticals for Human Use guidelines, applicable regulations and guidelines governing clinical study conduct, and the Declaration of Helsinki. Study-related documents were reviewed and approved by independent ethics committees and institutional review boards. All patients provided written informed consent.
: Not applicable.
: Hideto Kameda: Consulting fees, speaking fees, and/or honoraria: AbbVie GK, Asahi-Kasei, Bristol-Myers Squibb, Chugai, Eli Lilly Japan K.K., Gilead, Janssen K.K., Mitsubishi-Tanabe, Novartis, Pfizer Japan, Sanofi K.K., and UCB Japan. Research grants: AbbVie GK, Asahi-Kasei, Astellas, Chugai, Eisai, Mitsubishi-Tanabe, and Novartis.Tsutomu Takeuchi: Personal fees: AbbVie GK, Astellas, AYUMI, Bristol-Myers Squibb K.K., Boehringer-Ingelheim, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly Japan K.K., Gilead, GlaxoSmithKline K.K., Janssen K.K., Mitsubishi-Tanabe, Novartis K.K., Nipponkayaku, Pfizer Japan, Sanofi K.K., Taiho, Taisho, and UCB Japan. Grants: AbbVie GK, Asahi-Kasei, Astellas, AYUMI, Chugai, Daiichi-Sankyo, Eisai, Mitsubishi-Tanabe, Nipponkayaku, Novartis K.K., Pfizer Japan, Shionogi & Co., and Takeda. Speaker fees: AbbVie GK, Astellas, AYUMI, Chugai, Daiichi-Sankyo, Eisai, Gilead, Mitsubishi-Tanabe, Novartis K.K., Pfizer Japan, Sanofi K.K., Takeda, and Teijin. Consultant fees: Astellas, Boehringer-Ingelheim, Chugai, Janssen K.K., Mitsubishi-Tanabe, Nipponkayaku, Taiho, Taisho Toyama, and UCB Japan.Kunihiro Yamaoka: Speakers bureau: AbbVie GK, Astellas, Bristol-Myers Squibb, Chugai, Mitsubishi-Tanabe, Pfizer Japan, and Takeda.Motohiro Oribe and Mitsuhiro Kawano: None declared.Masayuki Yokoyama, Aileen L Pangan, Yuko Konishi, and Sebastian Meerwein: Employees of AbbVie and may own stock or options.Yoshiya Tanaka: Speaking fees and/or honoraria: AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eli Lilly, Eisai, Janssen, Mitsubishi-Tanabe, Novartis, Pfizer, Takeda, Teijin, and YL Biologics. Research grants: Asahi-Kasei, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Mitsubishi-Tanabe, Ono, Sanofi, Takeda, and UCB.
